Female sexual dysfunction

被引:5
|
作者
Kershaw, Victoria [1 ]
Jha, Swati [1 ]
机构
[1] Sheffield Teaching Hosp NHS Fdn Trust, Urogynaecol, Level 4,Jessop Wing, Sheffield S10 2SF, S Yorkshire, England
来源
OBSTETRICIAN & GYNAECOLOGIST | 2022年 / 24卷 / 01期
关键词
dyspareunia; female sexual dysfunction; genitopelvic pain disorders; hypoactive sexual desire disorders; orgasmic disorders; PELVIC ORGAN PROLAPSE; URINARY-INCONTINENCE; BOTULINUM-TOXIN; WOMEN; DYSPAREUNIA; DISORDERS; IMPACT; METAANALYSIS; PREVALENCE; INSTRUMENT;
D O I
10.1111/tog.12778
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Key content Female sexual dysfunction (FSD) is defined as any sexual complaint or problem resulting from disorders of desire, arousal, orgasm or sexual pain that causes marked distress or interpersonal difficulty. Various gynaecological problems such as pelvic organ prolapse and endometriosis affect sexual function and this impacts on their treatment. Management often requires the need to address different components of the sexual dysfunction. Women wish to keep their options relating to sexual function open well past the menopause, and more women are presenting in later life with FSD. Learning objectives To know how to assess FSD in clinical practice. To appreciate the reasons why all women attending a gynaecology clinic should have their sexual function assessed to establish a baseline. To establish realistic expectations of outcomes on sexual function following treatment of gynaecological problems. Ethical issues Failure to inform women of the risk of deterioration in sexual function following gynaecological surgery can lead to litigation. Some essential treatments, such as vulvectomy or prophylactic oophorectomy, will result in adverse effects on sexual function, and women should make informed choices regarding their treatment.
引用
收藏
页码:12 / 23
页数:12
相关论文
共 50 条
  • [1] Female Sexual Dysfunction
    Clayton, Anita H.
    Juarez, Elia Margarita Valladares
    [J]. PSYCHIATRIC CLINICS OF NORTH AMERICA, 2017, 40 (02) : 267 - +
  • [2] Female Sexual Dysfunction
    Reed, Michael A.
    [J]. CLINICS IN PLASTIC SURGERY, 2022, 49 (04) : 495 - 504
  • [3] FEMALE SEXUAL DYSFUNCTION
    READ, J
    [J]. INTERNATIONAL REVIEW OF PSYCHIATRY, 1995, 7 (02) : 175 - 182
  • [4] Female sexual dysfunction
    Berman, JR
    Goldstein, I
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 2001, 28 (02) : 405 - +
  • [5] Female Sexual Dysfunction
    Lindau, Stacy Tessler
    Abramsohn, Emily
    [J]. OBSTETRICS AND GYNECOLOGY, 2019, 134 (01): : E1 - E18
  • [6] Female sexual dysfunction
    Merkatz, RB
    [J]. JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE, 2002, 11 (04): : 331 - 333
  • [7] Female sexual dysfunction
    Goldstein, I
    Graziottin, A
    Heiman, JR
    Johannes, C
    Laan, E
    Levin, RL
    McKenna, KE
    [J]. ERECTILE DYSFUNCTION, 2000, : 509 - 556
  • [8] Female sexual dysfunction
    Korda, J. B.
    [J]. UROLOGE, 2008, 47 (01): : 77 - 89
  • [9] Female sexual dysfunction
    Erdogan Aslan
    Michelle Fynes
    [J]. International Urogynecology Journal, 2008, 19 : 293 - 305
  • [10] Female sexual dysfunction
    Fitzhenry, D
    Sandberg, L
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (02) : 99 - 100